Filing Details

Accession Number:
0001209191-15-033126
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-04-08 16:17:36
Reporting Period:
2015-04-06
Filing Date:
2015-04-08
Accepted Time:
2015-04-08 16:17:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
879169 Incyte Corp INCY Services-Commercial Physical & Biological Research (8731) 943136539
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1454983 S Richard Levy 1801 Augustine Cut-Off
Wilmington DE 19803
Evp, Chief Drug Dev Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-04-06 25,000 $18.32 46,227 No 4 M Direct
Common Stock Disposition 2015-04-06 25,000 $88.77 21,227 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2015-04-06 25,000 $0.00 25,000 $18.32
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
41,782 2020-02-08 No 4 M Direct
Footnotes
  1. Represents weighted average sale price. Actual sale prices ranged from $87.55 - $90.03.
  2. Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
  3. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
  4. Beginning February 9, 2013, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.